150356-53-9 Usage
Uses
Used in Pharmaceutical Synthesis:
BETA-OXO-3-(PHENYLMETHOXY)-BENZENEPROPANOIC ACID METHYL ESTER is used as an intermediate in the synthesis of β-(m-Hydroxyphenyl)hydracrylic Acid (H949280) for its role as a urinary metabolite of phenylalanine from the Clostridium gram-positive bacteria cell line. This application is significant for understanding the metabolic pathways and potential therapeutic targets in bacterial infections.
Used in Metabolite Research:
In the field of metabolomics, BETA-OXO-3-(PHENYLMETHOXY)-BENZENEPROPANOIC ACID METHYL ESTER is used as a reference compound for the identification and quantification of urinary metabolites of Rutin (R701800), a capillary protectant found in plants. This application aids in the study of plant biochemistry and the potential therapeutic effects of plant-derived compounds.
Used in Chemical Synthesis:
BETA-OXO-3-(PHENYLMETHOXY)-BENZENEPROPANOIC ACID METHYL ESTER is utilized as a key building block in the synthesis of various organic compounds, particularly those with pharmaceutical or agrochemical applications. Its unique structure allows for further functionalization and modification, making it a valuable asset in the development of new molecules with potential biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 150356-53-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,0,3,5 and 6 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 150356-53:
(8*1)+(7*5)+(6*0)+(5*3)+(4*5)+(3*6)+(2*5)+(1*3)=109
109 % 10 = 9
So 150356-53-9 is a valid CAS Registry Number.
150356-53-9Relevant academic research and scientific papers
METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF
-
, (2016/01/01)
Provided herein are small molecule active metabotropic glutamate subtype-2 and -3 receptor negative allosteric modulators (NAMs), compositions comprising the compounds, and methods of using the compounds and compositions.
Endothelin receptor antagonists
-
, (2008/06/13)
Novel indane and indene derivatives are described which are endothelin receptor antagonists.
